15-ADON | 15-acetyldeoxynivalenol |
3-ADON | 3-acetyldeoxynivalenol |
Aβ | amyloid beta |
ACN | acetonitrile |
AD | Alzheimer´s disease |
AFB1 | aflatoxin B1 |
AFB2 | aflatoxin B2 |
AFG1 | aflatoxin G1 |
AFG2 | aflatoxin G2 |
AFM1 | aflatoxin M1 |
CIRS | chronic inflammatory response syndrome |
CNT | control |
DAS | diacetoxyscirpenol |
DOM-1 | deepoxy-deoxynivalenol |
DON | deoxynivalenol |
FUS-X | fusarenon-X |
GDS | Global Deterioration Scale |
HBM | human biomonitoring |
HY | Hoehn and Yahr |
LC | liquid chromatography |
LC-MS/MS | liquid chromatography coupled to mass spectrometry in tandem |
LOD | limit of detection |
LOQ | limit of quantification |
NEO | neosolaniol |
NIV | nivalenol |
OTA | ochratoxin A |
OTA-d5 | ochratoxin A-(phenyl-d5) |
OTB | ochratoxin B |
PD | Parkinson´s disease |
q | transition of qualification |
Q | transition of quantification |
QqQ | triple quadrupole |
RE | relative error of the mean |
SD | standard deviation |
STER | sterigmatocystin |
ZEA | zearalenone |